Replies to post #277838 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

But, this wasn't one of them.

Falconer - Thanks for your many, many important and valuable contributions to this board.

Thank you. Fortunately, my statements concerning sigma-1 receptor biochemistry have been far more accurate than my Anavex arithmetic. As a number of helpful postings mention, my numbers, concerning eventual Anavex revenues and share price projections are off.

The purpose, however, was to prompt, from those more financially competent, thoughts on eventual financial numbers, when the company is able to sell blarcamesine. Interested readers can now do that.

Simply, a share of AVXL will be worth more than today's $5. A lot more. As mentioned, my brokerage will be getting a check from my bank tomorrow, with which I'll expand my AVXL accumulation. The only thing jeopardizing it would be the failure of blarcamesine in all three of the current human trials. Not a shred of evidence that will happen, either from murines or humans.

My arithmetic can be questioned, appropriately. But positive clinical results, soon to more completely emerge, will substantiate my understandings and explanations of the biochemistry of blarcamesine. For those of us who hold any of the (yes) 60,191,000 shares of AVXL, we will be wonderfully rewarded.

And, lastly, actually far more significant and important, will be the greatly improved well-being of millions suffering from various central nervous system diseases. Nothing better than that.